5 Followers USX:NVTA - Invitae Corp (USD 13.29) Invitae Corp
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   


Yahoo Finance

USD 13.29    -0.240 (-1.77%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


Overview

9 Apr 2020

Day Change: -0.240 (-1.77%)

52 Wk Range: 7.415 - 28.75

Day's Range: 13.02 - 14.24

Last Volume: 2,219,895

Current Yield: 0%

Projected Yield: 0%

Open: USD 13.86

9 Apr 2020

Metric NVTA S.Median
Beta 1.72 0.84
VaR 46.5 25.23
E.Shortfall 70.68 45.03
Liquidity 2.99M 95.2K

Fundamental

9 Apr 2020

PE:

Market Cap: 3.8B

Price Over Book: 9.442

Price Over Sales: NA

Return On Assets:

Return On Equity:

Price Over NAV: [Friends Only]

General

CEO: Sean E. George

Headquarters: San Francisco

Employees: 788

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

Invitae Corporation, a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare in the United States, Canada, Israel, and internationally. The company processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. It provides a diagnostic service comprising hundreds of genes for various genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. The company also offers solutions that enable sharing of genetic information consisting of Invitae Family History Tool, an online portal and mobile application that communicates sensitive patient data. In addition, it provides gene sequencing and deletion/duplication analysis; and free re-requisition of additional data within the same indication when ordered, as well as invests in informatics solutions and infrastructure that enable sharing of genetic information to enhance healthcare and clinical outcomes. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.